Organon & Co. (OGN) Stock Forecast
Data as of Jun 17, 2026Healthcare · Current price $13.43 (-0.04%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 27, 2025 | David Amsellem | Piper Sandler | $5.00 | -62.8% |
| May 15, 2025 | David Amsellem | Piper Sandler | $18.00 | +34.0% |
| May 5, 2025 | Terence Flynn | Morgan Stanley | $10.00 | -25.5% |
| Apr 29, 2024 | David Amsellem | Piper Sandler | $24.00 | +78.7% |
| Jun 26, 2023 | David Amsellem | Piper Sandler | $34.00 | +153.2% |
Top Analysts Covering OGN
OGN vs Sector & Market
| Metric | OGN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.33 | 2.24 | 2.40 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | -15.8% | +11475.1% | +17.1% |
| P/E Ratio | 14.44 | 3.90 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $1.53B | $1.58B | $1.60B | 2 |
| 2026-09-30 | $1.55B | $1.58B | $1.59B | 1 |
| 2026-12-31 | $1.51B | $1.54B | $1.55B | 1 |
| 2027-03-31 | $1.51B | $1.53B | $1.55B | 1 |
| 2027-06-30 | $1.57B | $1.60B | $1.62B | 1 |
| 2027-09-30 | $1.54B | $1.56B | $1.58B | 1 |
| 2027-12-31 | $1.53B | $1.56B | $1.58B | 1 |
| 2028-12-31 | $6.36B | $6.36B | $6.36B | 4 |
| 2029-12-31 | $6.32B | $6.46B | $6.55B | 3 |
| 2030-12-31 | $6.37B | $6.50B | $6.60B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.90 | $0.93 | $0.97 | 4 |
| 2026-09-30 | $0.93 | $0.95 | $0.97 | 1 |
| 2026-12-31 | $0.73 | $0.75 | $0.76 | 2 |
| 2027-03-31 | $0.90 | $0.92 | $0.93 | 2 |
| 2027-06-30 | $1.02 | $1.04 | $1.06 | 1 |
| 2027-09-30 | $0.99 | $1.01 | $1.03 | 1 |
| 2027-12-31 | $0.69 | $0.71 | $0.72 | 2 |
| 2028-12-31 | $3.86 | $3.97 | $4.04 | 1 |
| 2029-12-31 | $3.69 | $3.80 | $3.87 | 1 |
| 2030-12-31 | $3.79 | $3.90 | $3.97 | 1 |
Frequently Asked Questions
What is the analyst consensus for OGN?
The consensus among 3 analysts covering Organon & Co. (OGN) is Hold with an average price target of $11.33.
What is the highest price target for OGN?
The highest price target for OGN is $34.00, set by David Amsellem at Piper Sandler on 2023-06-26.
What is the lowest price target for OGN?
The lowest price target for OGN is $5.00, set by David Amsellem at Piper Sandler on 2025-10-27.
How many analysts cover OGN?
3 analysts have issued ratings for Organon & Co. in the past 12 months.
Is OGN a buy or sell right now?
Based on 3 analyst ratings, OGN has a consensus rating of Hold (3.33/5) with a -15.8% upside to the consensus target of $11.33.
What are the earnings estimates for OGN?
Analysts estimate OGN will report EPS of $0.93 for the period ending 2026-06-30, with revenue estimated at $1.58B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.